The secure way to view our annual materials and vote your proxy.
View an enhanced version of our Annual Report.
View an enhanced version of our Proxy Statement.
You may request paper copies of the proxy materials online now, by email or by phone by dialing 866-648-8133.
Your vote is important!
Vote your proxy online now or vote by phone
by dialing 866-437-3790 .
June 12, 2026
10:00 a.m. Pacific Time
LENZ Therapeutics is pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia. LENZ is commercializing VIZZ® in the United States and continues to establish licensing partnerships internationally to provide access to VIZZ® globally. LENZ is headquartered in San Diego, California.
Copyright © BetaNXT, Inc. or its affiliates. All rights reserved.